Cartalax 20mg
$59.99
Cartalax 20mg tripeptide bioregulator for laboratory research. Supplied as lyophilized peptide for studies involving cellular signaling, gene expression, and peptide regulatory pathways.
In stock
Description
Cartalax | 20mg | Tripeptide Bioregulator
Description
Cartalax is a short-chain tripeptide bioregulator identified by the amino acid sequence Glu-Asp-Gly. In laboratory research, it is studied as a low-molecular-weight peptide model relevant to cellular signaling, tissue-specific peptide regulation, and peptide-mediated gene expression pathways.
Due to its compact structure, Cartalax is commonly referenced in experimental systems investigating how short peptides interact with cellular regulatory mechanisms. Research interest has focused on its role in cellular communication, differentiation processes, and age-associated changes in tissue function under controlled in vitro conditions.
Short-chain peptides such as Cartalax are frequently utilized in studies exploring peptide bioregulators and their relationship to cellular renewal, molecular signaling, and tissue-specific response pathways. These characteristics make it relevant in broader research examining peptide-driven regulatory systems.
This vial contains 20mg of lyophilized Cartalax peptide intended strictly for controlled in vitro laboratory research applications.
Specifications
- Unit Size: 20mg (lyophilized powder, single vial)
- Amino Acid Length: 3 amino acids
- Sequence: Glu-Asp-Gly
- Molecular Weight: ~879 Da
- Form: Crystalline lyophilized peptide
- Solubility: Soluble in sterile water or compatible aqueous laboratory buffers
- Storage: Store dry at 2–8°C. After reconstitution, refrigerate at 2–8°C and avoid repeated freeze-thaw cycles.
Research Applications
Peptide Bioregulator Research
Cartalax is studied in laboratory environments as a representative tripeptide bioregulator, particularly in experimental work examining how small peptides influence cellular communication and regulatory signaling pathways.
Cellular Signaling and Gene Expression Studies
Research involving short-chain peptides often utilizes compounds such as Cartalax to investigate cellular signaling mechanisms and gene expression modulation, particularly in models examining peptide-driven regulatory processes.
Aging and Cellular Stress Research
Cartalax is referenced in studies exploring age-related cellular changes and stress-response pathways. These models investigate how peptide signaling may influence cellular maintenance, repair mechanisms, and adaptive responses under controlled laboratory conditions.
Stem Cell and Differentiation Models
Laboratory research involving stem cell biology and cellular differentiation sometimes includes tripeptide compounds such as Cartalax to examine how peptide signals may affect developmental pathways and cellular behavior.
Intended Use
This compound is intended strictly for in vitro laboratory research use only. It is not approved for human or animal administration and must not be used in food, dietary supplements, cosmetics, pharmaceuticals, or diagnostic procedures.
Use is restricted to qualified research professionals operating in certified laboratory environments and in compliance with all applicable regulations.
Legal Disclaimer
This product and its associated information have not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding diagnosis, treatment, cure, or prevention of disease.
All information is provided strictly for scientific and educational purposes. The purchaser assumes full responsibility for proper handling, storage, and research use of this compound.
Terms of Sale
By purchasing from American Wholesale Peptides, the buyer affirms they are a qualified researcher or institution and accepts full responsibility for lawful handling, storage, and research use of this compound.
- For lawful in vitro laboratory research only
- Not approved for human or veterinary use
- All sales are final




